Gloria Bellonia, Author at Swiss Vaccine Research Institute - Page 10 of 10

Schaeuble K., Cannelle H., Favre S., Huang H.Y., Oberle S.G., Speiser D.E., Zehn D., Luther S.A.

Jul 15, 2019 | Publications

Attenuation of chronic antiviral T-cell responses through constitutive COX2-dependent prostanoid synthesis by lymph node fibroblasts

Moore C.L., Stöhr W., Crook A.M., Richert L., Leliévre J.D., Pantaleo G., García F., Vella S., Lévy Y., Thiébaut R., McCormack S.

May 6, 2019 | Publications

Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions

Julg B., Dee L., Ananworanich J., Barouch DH., Bar K., Caskey M., Colby D.J., Dawson L., Dong K.L., Dubé K., Eron J., Frater J., Gandhi R.T., Geleziunas R., Goulder P., Hanna G.J., Jefferys R., Johnston R., Kuritzkes D., Li J.Z., Likhitwonnawut U., van Lunzen J., Martinez-Picado J., Miller V., Montaner L.J., Nixon D.F., Palm D., Pantaleo G., Peay H., Persaud D., Salzwedel J., Salzwedel K., Schacker T., Sheikh V., Søgaard O.S., Spudich S., Stephenson K., Sugarman J., Taylor J., Tebas P., Tiemessen C.T., Tressler R., Weiss C.D., Zheng L., Robb M.L., Michael N.L., Mellors J.W., Deeks S.G., Walker B.D..

Apr 6, 2019 | Publications

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting

Next Entries »